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Abstract
Background: Less than one third of publicly funded trials managed to recruit according to their original plan
often resulting in request for additional funding and/or time extensions. The aim was to identify models which
might be useful to a major public funder of randomised controlled trials when estimating likely time requirements
for recruiting trial participants. The requirements of a useful model were identified as usability, based on
experience, able to reflect time trends, accounting for centre recruitment and contribution to a commissioning
decision.
Methods: A systematic review of English language articles using MEDLINE and EMBASE. Search terms included:
randomised controlled trial, patient, accrual, predict, enrol, models, statistical; Bayes Theorem; Decision Theory;
Monte Carlo Method and Poisson. Only studies discussing prediction of recruitment to trials using a modelling
approach were included. Information was extracted from articles by one author, and checked by a second, using a
pre-defined form.
Results: Out of 326 identified abstracts, only 8 met all the inclusion criteria. Of these 8 studies examined, there are
five major classes of model discussed: the unconditional model, the conditional model, the Poisson model,
Bayesian models and Monte Carlo simulation of Markov models. None of these meet all the pre-identified needs of
the funder.
Conclusions: To meet the needs of a number of research programmes, a new model is required as a matter of
importance. Any model chosen should be validated against both retrospective and prospective data, to ensure the
predictions it gives are superior to those currently used.
Background
Large scale multicentre randomised controlled trials
(RCTs) are regarded as the gold standard in rigorous,
robust clinical research. Participants are recruited across
a number of centres and are randomly assigned to con-
trol or intervention groups. Rates of participant recruit-
ment, however, are not as straightforward as it may
seem and this can have an enormous impact on the
planning, execution and funding of trials. Failure to
recruit sufficient numbers of participants, or extended
delays in recruitment can have serious implications for
the success or otherwise of the trial.
Research funders usually require applicants to calcu-
late how many participants they require to answer their
identified research questions, and how long they will
need to recruit those participants into their study. In
deciding how long they will require to accrue partici-
pants, trialists are often over optimistic - in 2007 Camp-
bell found that less than one third of publically funded
trials managed to recruit according to their original plan
[1]. In some sectors this problem affects up to 80% of
studies [2]. Careful planning and preparation can give
better estimates of how realistic a particular accrual tar-
get is, and how long it will take to recruit the required
number of patients.
As the leading public funder of clinical trials in the
United Kingdom, the NIHR Health Technology Assess-
ment (HTA) programme has an interest in optimising
its investment in trials - and one way in which it can do
this is by ensuring good estimates of timescales for
research are available at the time of taking funding
decisions.* Correspondence: k.barnard@soton.ac.uk
National Institute for Health Research Evaluation, Trials and Studies
Coordinating Centre (NETSCC), University of Southampton, UK
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In order to get good estimates, accurate and realistic
patient recruitment predictions are required. Unfortu-
nately, most HTA applicants adopt the unconditional
approach [3] to recruitment prediction - suggesting that
all their planned centres will start recruiting to their
maximum capacity on day one. These centres tend not
to be a pre-existing trial network, but are recruited on
an ad-hoc basis for the needs of the trial. Given the dif-
ficulties with ethical and research governance approval
at individual centres, this rarely happens.
As the application process is competitive - multiple
teams compete to be commissioned to answer a single
question - it might be expected that applicants overesti-
mate their ability to recruit patients to trials, in order to
make their applications appear more attractive. This
appears to be borne out by 70% of trials failing to meet
their original recruitment targets and requiring either
additional time and money, or reconsidering the power
of their study [4].
In order to facilitate the work of the HTA programme,
and other research funders, the authors set out to inves-
tigate whether it would be feasible to provide a model
for applicants intending to carry out pragmatic clinical
trials to use to improve the prediction of recruitment to
trials. The project to deliver this tool was divided into
two phases. The first phase was a systematic literature
review to identify currently existing tools and assess
whether they met the programmes requirements. The
objective of the second phase was to produce and test a
predictive model for the HTA programme - through
either building on a model found in phase 1, or starting
from scratch.
This paper reports phase one - the systematic litera-
ture review.
Methods
For a predictive recruitment model to be useful to a
wide group of stakeholders - including researchers and
funders - it must exhibit certain characteristics, i.e. be:
1. Simple to Use and Understand - Applicants
should be able to describe their proposed trial, and
the model should provide the likely recruitment
profile.
2. Can adapt to epidemiological changes - reflecting
the research community’s previous experience of the
ability of studies to recruit patients and centres in
the area of the trial.
3. Can adapt to environmental changes - changes
affecting the conduct of trials in general for example,
changes in ethical approval processes or regulatory
requirements which then alter the lead time required
to add a centre to a trial.
4. Able to take account of centre recruitment - The
promptness of centres starting to recruit patients is
a significant driver for overall recruitment in multi-
centre trials.
5. Able to inform commissioning decisions - The
model should provide an expected recruitment per-
iod to allow proposals to be compared, rather than a
probabilistic analysis.
We set out to identify existing models, and assess
them against these criteria.
To identify currently existing models, a systematic lit-
erature review was conducted. Medline and Embase
were searched in July 2008. The following truncated free
text terms were searched in the title and abstract fields
for: ((subject$ or patient$ or projected or accrual or fail
$ or stop$ or clos$ or shut or predict$ or estimat$)
adj5 (recruit$ or particip$ or enlist$ or enrol$)); plus
MeSH terms “Patient Selection” or “Sample Size”.
Model types and statistical methods were also searched
for: models, theoretical; models, organizational; models,
statistical; Bayes Theorem; Decision Theory; Monte
Carlo Method; Stochastic Processes; Clinical Trials Data
Monitoring Committees; Data Interpretation, Statistical;
Statistics; Poisson Distribution; normal distribution.
The papers identified by the search were reviewed by
KB and AC to ensure all appropriate identified studies
were included. Non-English language papers were
excluded, due to a lack of resource for translation.
Papers were excluded if they did not discuss using mod-
elling techniques to predict patient recruitment to indi-
vidually randomised clinical trials.
In order to identify candidate papers in the grey litera-
ture which may not be included in standard databases sub-
sidiary searching was carried out using the Google search
engine. No papers were found which were not identified
through the formal search strategy (see Figure 1).
Data was extracted from the identified papers using a
pre-defined data-extraction form. Data was extracted by
KB initially and was then checked by LD and AC.
The categories used in the form were
1. question the identified model was designed to
address, where not explicitly stated in the paper this
is as determined by the reviewers
2. applicability of the model to the needs of the
HTA programme and other pragmatic trial funders
(eg to multi-centre studies, ad-hoc centres)
3. Approach of the model - the mathematics of the
model, what data was used to populate the model,
how it was validated
4. Centre Recruitment - did the model consider
recruitment of both centres and individual patients?
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Results
Three hundred and twenty six papers were identified in
the initial search, none of these were duplicates.
Following the initial screen of abstracts, 306 were
excluded as the title indicated they did not address
modelling of trial recruitment. Full papers were assessed
for 20 studies.
Following the full paper review, 12 studies were
excluded as they did not address modelling of trial
recruitment.
A summary of this process is shown in the PRISMA
diagram in Figure 1[5]
The 8 studies included are summarised in the sum-
mary of study data extraction (Additional file 1).
Of the 8 studies examined, there are five major classes
of model discussed: the unconditional model, the condi-
tional model, the Poisson model, Bayesian models and
Monte Carlo simulation of Markov models (see Table 1
for a summary of these types of model).
Carter’s 2005 paper [3] considers the conditional
model, a deterministic approach is also discussed by
Moussa [6]. The conditional model, is a development
of the unconditional model which is commonly used
by applicants for NIHR HTA programme grants. The
conditional model allows the expected recruitment in
any given month to vary, depending on other condi-
tions within the trial such as how many centres are
available to recruit. This more closely matches the real
life experience of multi-centre trials relying on ad-hoc
centre recruitment. Using relatively simple calculations
this model can easily be constructed within a
spreadsheet.
Three papers considered Poisson modelling [3,7,8]. Of
these, two are linked, with one addressing the theory [4]
and the other discussing a practical use of the method
[4]. Carter (2005) [3] presents the effect of these models
on a trial protocol in development. As the prediction
models become more sophisticated, the predicted
accrual periods become longer. It should be noted that
the mean predicted accrual periods for the conditional
and Poisson approaches are very similar at 23 months
and 23.2 month respectively. Anisimov [7] takes a simi-
lar approach to Carter (2005), in that he constructs a
Poisson based model, but allows the recruitment rate to
vary according to a Gamma distribution. He makes no
allowance for varying the number of recruiting centres
over time.
Williford considers the relative advantages of the Pois-
son and Bayesian approaches in monitoring ongoing
recruitment within a trial and predicting future goals [8].
Gajewski develops the Bayesian approach of Williford
to include establishing prior probabilities without
requiring accrual data from a specific trial [9]. His initial
prior probability is derived from either previous experi-
ence in similar trials, or from clinical opinion based on
epidemiology. As more trial specific accrual data
becomes available, the prediction can be refined by
bringing this data into the calculation.
Abbas [10] uses a number of Markov models to
explore the maximisation of recruitment of patients in a
minimum amount of time. He starts from the assump-
tion of a fixed set of centres. He does present the only
approach that deals with depleting willing trial partici-
pants from a population and the effect this has on the
length of an accrual period. Abbas does not however
consider the recruitment of trial centres - which could
have an effect on reducing the effect of exhaustion of
the trial pool.
Hadich [11]uses a time series approach to analyse
an existing set of data retrospectively, to determine
if it would have been possible to predict recruitment
to a trial. This time series model is not validated
prospectively.
The characteristics of the identified models were com-
pared to the criteria initially established, a summary of
the comparison is shown in Table 2.
Comparing the different model types identified in this lit-
erature it becomes clear that the unconditional model does
not fulfil sufficient of the pre-identified criteria because it is
too simple and cannot take account of changes in centre
recruitment or regulatory environment. The conditional
model has promise because it satisfies all the criteria, how-
ever it has no fixed structure so a new model must be con-
structed for each use. The poisson model is promising, as
using Carter 2004’s illustrations you can allow lambda to
vary for different periods of time in the trial as additional
Figure 1
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centres start recruiting. This involves simulating and com-
bining data from a number of different poisson distribu-
tions which complicates the model slightly. The possion
model can be further enhanced by allowing lambda to vary
according to a gamma or uniform distribution as illustrated
by Carter (2005), Amnisov and Williford. It is not clear
from the literature exactly how centre recruitment can be
taken into account in the poisson-gamma model and if this
additional level of complexity is necessary. Baysian models
rely on data being available to establish prior probabilities
of recruitment which can be updated over the course of
the study, making them more challenging to use for com-
missioning decisions, as they become more accurate as
more trial data becomes available. Therefore, they are of
more benefit when taking continuation decisions over the
course of a trial. Markov models require structural model
changes each time they are used, they are comparatively
complex (especially when compared to conditional models)
and there are no examples in the papers found of Markov
approaches incorporating variations in study centre
recruitment.
Five articles used recruitment data from existing trials
to illustrate their model or establish the structure and
parameters used in their models, whilst three presented
analysis based on theoretical data only (Table 3). Only
two papers tested the fit of their proposed models using
trial recruitment data, Anisomov and Williford [7,8].
Wiliford compared the fit of the poisson to the nega-
tive-binomial (poisson-gamma) model, while Anisomov
focused solely on the poisson-gamma model. They con-
cluded there is some evidence that the poisson-gamma
model provides an acceptable fit for trials with more
than 200 participants 8] and more than 20 centres [6].
However, Williford questioned its usefulness for any
pre-study prediction unless the distribution of changes
in patient intake rates can be estimated and modelled.
Discussion
There are two significant drivers to overall recruitment
in pragmatic multicentre randomised controlled trials
unable to take advantage of a pre-existing network of
recruiting centres: recruitment of patients, and recruit-
ment of centres.
All of the studies identified primarily considered
recruitment of patients. Five of the 8 studies did not
consider the role of centre recruitment at all. The others
discuss this as an issue, but make no explicit effort to
include this important parameter in their model.
Table 1 Definitions of the different types of models
Model Definition
Unconditional model The unconditional approach estimates the accrual period by dividing the pre-specified sample size by the number of
patients they expect to recruit across all centres each month (e.g. assume a trial requires 400 participants, its
estimated centres will recruit 10 participants per month. According to the unconditional model this implies it will
take 40 months to recruit all 400 participants. 2
Conditional model The conditional model allows the expected recruitment in any given month to vary, depending on other conditions
in the trial such as how many centres are available to recruit (e.g. assume a trial requires 400 participants and that its
expected centres 1 and 2 will start recruiting in month 1 and will recruit 5 participants per month each. Also assume
its expected that centre 3 will start recruitment in month 6 and will recruit 10 participants per month. According to
the conditional model this implies it will take 22.5 months to recruit all participants).2
Possion model The poisson models, assumes the rate that participants are recruited varies according to a poisson distribution. The
number of participants recruited within a given month is simulated using a random number generator, from the
poisson distribution with mean l, where l is the mean number of participants that trialists specify they expect to
recruit each day/month. The Poisson distribution is a discrete probability distribution that expresses the probability
of a number of events occurring in a fixed period of time if these events occur with a known average rate (l) and
independently of the time since the last event. P(Xt = n) = (e
-lt (lt)n )/n!2
Bayesian model A Bayesian analysis starts with a “prior” probability distribution for the value of interest (for example, the recruitment
of participants into a trial)–based on previous knowledge–and adds the new evidence as data accumulates (via a
model) to produce a “posterior” probability distribution. 10
Monte carlo simulation
Markov model
A type of quantitative modeling that involves a specified set of mutually exclusive and exhaustive states (e.g., of a
given health status), and for which there are transition probabilities of moving from one state to another (including
remaining in the same state). In this case a participant moving from a contacted state to a recruited state in a
specified time period. Typically, states have a uniform time period, and transition probabilities remain constant over
time.
Values are randomly generated from a uniform distribution, if the value generated is less than equal to the transition
probability assumed a participant is said to be recruited in that time period.
Monte Carlo simulation considers random sampling of probability distribution functions as model inputs to produce
hundreds or thousands of possible outcomes instead of a few discrete scenarios. The results provide probabilities of
different outcomes occurring.
Markov chain monte carlo simulations use, monte carlo simulation (random number generation) to decide on the
transition probability and whether a participant moves from one state to another (is recruited in this time period or
not).8,11
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The HTA programme experience has been that poor
centre recruitment (often due more to issues of process
than clinician engagement) is a significant issue in caus-
ing trials to miss their recruitment targets.
For example, SANAD - a trial comparing various anti-
epileptic agents - ran into difficulties in expanding its
centres due to competition from other trials in epileptics
underway at the same time [12]. The trial managed to
attain 90 centres, but not as quickly as was originally
anticipated.
PAC-MAN, an investigation into the use of pulmonary
artery catheters in intensive care units had difficulty
recruiting centres due to the procedure which was then
in place for seeking ethics approval [13]. Of 95 intensive
care units which expressed an interest in participation,
only 79 eventually completed all the required processes
to join the trial, and only 65 recruited at least one
patient. At one stage the trial dropped to only recruiting
40% of the predicted number of patients.
REFLUX was a trial investigating surgery in gastro-
oesophageal reflux disease [14]. Similarly to PAC-MAC
[13] difficulties with ethics resulted in the slow accumu-
lation of centres, resulting in an extension of both time
and money in order for the trial to meet its patient
recruitment targets.
This review is not without limitation, for example, lit-
erature searches may not have identified unpublished or
grey literature. While we are confident that we have
complete coverage of relevant studies in the formal
indexes, it would not be surprising had we failed to
identify relevant information in the grey literature -
especially anything which was not published in English.
However, it seems to us likely that we have identified at
least one example of each of the classes of approach
which could be used to address this issue.
A further limitation may be the assessment criteria
against which we judged the models. These were derived
from discussions within the scientific secretariat at the
Table 2 Match between identified models with requirements of HTA programme













Simulation using Poisson distribution Y P Y Y Y
Carter
(2005)
Unconditional Y Y N N Y
Conditional Y Y Y Y Y
Simulation using Poisson distribution Y P Y Y Y
Simulation using Poisson distribution with average
recruitment rates (l) varied according to a uniform
distribution
Y P Y Y Y
Anisimov
(2007)
Poisson process with recruitment rates (l) viewed as
a sample from a gamma distribution
N Y Y N P
Moussa
(1984)
Conditional Y Y Y N Y
Williford
(1987)
Poisson N Y Y N N
Negative binomial (Poisson process with recruitment
rates (l) viewed as a sample from a gamma
distribution)
N Y Y Y N
Lees contagious poisson N Y Y Y N
Bayesian - prior distribution is possion-gamma,
posterior is gamma
N Y Y N N
Gajewski
(2007)
Bayesian - prior distribution is the inverse gamma,
likelihood is the exponential distribution, posterior
distribution is the inverse gamma
N Y Y P Y
Abbas
(2007)
Markov N P Y N Y
Hadich
(2001)
Time series N P N N N
Y = Criterion met
N = Criterion not met
P = Posssibly: Criteron could be met, dependent on circumstance
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NIHR Evaluation, Trials and Studies Coordinating Cen-
tre. This is the group which supports the HTA pro-
gramme - consequently it is possible that the criteria
that we used give emphasis to aspects of models which
the HTA programme would particularly value. Had
these criteria been developed by another group they
may have developed a differing set.
In order for a model to be useful, trialists need to take
into account local factors which influence a model’s para-
meters. Examples would include delays in trialist and
centre start times caused by variations in local ethics and
local governance approvals or the existence of trials com-
peting for the same patient pool. Delays caused by gov-
ernance processes could be estimated from the previous
experience of trialists or programmes making decisions.
Patient competition must be estimated from knowledge
of ongoing or planned trials, potentially run or funded by
other groups and estimates of those factors could be used
to adjust the parameters used in the predictive model -
for example by reducing the expected number of patients
recruited while a competitive trial is underway.
It is in the nature of pragmatic trials that an ad-hoc
set of centres is required for each trial. The topics com-
missioned by the programme are so varied that a stand-
ing trial network would not usually be useful. There are
advantages to be gained from a standing network -
experience, habituation to trial recruitment and a pool
of identified potential trial participants being examples.
It is hoped that the NIHR research networks will in
future aid with recruitment to trials in the UK- fulfilling
in part the role of a standing trial network.
There appears to be a gap for a tool to predict recruit-
ment to clinical trials of ad-hoc networks, which would
account for both centre and patient recruitment, and
recognise that one will drive the other. Such a tool might
be built on the conditional, Poisson or Poisson-gamma
models - although the model comparison in Table 3 sug-
gest that the conditional model is the leading candidate.




Where From/How Was Prediction Useful/authors conclusions in relation to
the model and data used
Carter
2004
No Theoretical example only Not applicable
Carter
2005
Yes They used information from a multicentre RCT protocol under
development to test and illustrate the three models
The authors conclude that the unconditional approach can
yield results not consistent with trial assumptions and may
endanger the successful completion of the trial. The models
are sensitive to the estimated accrual rate and the conditional
and poisson accrual estimation methods maybe useful to
researchers designing a complex, multi-center RCT.
Anisimov Yes Checked how a poisson-gamma model fits real recruitment
data by analysing several tens of completed GSK trials in
different therapeutic areas.
Authors conclude that for a sufficiently large number of
centres (N > 20) the poisson-gamma model is in good
agreement with real data and can serve as a basic
recruitment model.
Moussa No Theoretical analysis only Not applicable
Williford Yes Analysed weekly patient intake data from 9 multihospital
clinical trials coordinated by the Veterans Administration
Coordinating Centre between 1975 and 1982. Used the data
to review how mean patient intake varies over time within a
trial, and whether the assumption of equal patient intake rates
throughout a trial is appropriate. Used trial data to compare fit
of poisson model to a negative-binomial model
Authors conclude:
1. poisson distribution did not always provide an acceptable
fit, nor was the assumption of equal intake rates over three
time periods in a trial acceptable.
2. There is some evidence that the negative binomial
distribution might provide an acceptable fit for trials with
more than 200 patients. However, this distribution does not
lend itself to any pre-study prediction unless the distribution
of changes in patient intake rates can be estimated and
modelled
Gajewski Yes To illustrate the proposed model the authors use data from
the Kansas University DHA outcome study which is a single
centre trial. They take enrolment dates of the first 41 patients
recruited and use these to predict the time needed to recruit
the remaining 309 patients.
Unclear, the authors don’t discuss how long the trial actually
took to recruit all patients and compare that to the time
predicted from the model. They use the data to illustrate the
model only.
Abbas No Hypothetical examples presented Not applicable
Haidich Yes A retrospective analysis of database of all 782 clinical studies
launched by the AIDS Clinical Trials Group between Oct 1986
and Nov 1999 to identify factors which affect recruitment (use
simple regression and multivariate first-order autoregressive
model). Model not applied to other trials.
Authors conclude modelling enrolment rates may be used to
comprehend long-term patterns and to perform future
strategic planning.
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Bayesian models, however, show promise for use during
the conduct of a trial.
The possible attraction of a more sophisticated model
is the confidence interval it can place around the accrual
period estimate. The major trade-off would be the
increased complexity of use of the Bayesian or Poisson
based models compared to the relative simplicity of the
deterministic conditional model. Given Carter’s (2005)
findings that there was very little difference in predic-
tion between the Poisson and conditional models he
used, the relative simplicity of the conditional model
may be more attractive [3]. It should be noted that all
the models are heavily dependent on the parameters
used (e.g. estimates of monthly recruitment of partici-
pants). The confidence intervals from the Bayesian and
Poisson models do not reflect the inaccuracy of the
model parameters - but more the distributions described
by those parameters. The provided confidence levels
may therefore offer a false degree of security in the con-
fidence of the estimates produced by the models.
The ease of implementation of a model would also
contribute to which method should be used. A model
which could be operated by an applicant on their own
computer, or alternatively online, might be preferred
over one which required significant statistical expertise
to implement and use. Alternatively, recruitment predic-
tion could become a service offered by local Clinical
Trials Units, or Research Design Services, which may
allow more sophisticated tailoring of models to the par-
ticular circumstance which a trialist encounters.
The NIHR research programmes do not currently have a
preferred model for clinical trial prediction, consequently
most applicants choose the simplest - the unconditional
model. The programmes could give consideration to giv-
ing guidance on prediction of recruitment to applicants -
and especially for them to include centre recruitment in
their model. They may wish to suggest appropriate meth-
ods to use for recruitment prediction, mandate a particular
existing model, or design their own model. As we move
towards developing a new model, we will have to consider
the conflicting needs for simplicity and estimation - possi-
bly by developing more than one model and testing which
gives the more useful predictions. Any model chosen
should be validated against both retrospective and pro-
spective data, to ensure the predictions it gives are super-
ior to those currently used.
Conclusion
To meet the needs of a number of research pro-
grammes, a new model is required as a matter of impor-
tance. Any model chosen should be validated against
both retrospective and prospective data, to ensure the
predictions it gives are superior to those currently used
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